FDA, Defense to share patient data in bid to improve safety in the US
This article was originally published in Clinica
The US Food and Drug Administration and the Department of Defense (DoD) have agreed to share patient information in an effort to improve their mutual understanding of the safety of medical devices, drugs and biologics and how patients use them, writes April Fulton.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.